Railway Pension Investments LTD Nektar Therapeutics Transaction History

Railway Pension Investments LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 22, 2020	SELL	$14.47 - $27.96 $3.1 Million - $5.98 Million	-213,897 Closed	0 $0
Q4 2019 Feb 03, 2020	SELL	$15.87 - $23.12 $607,598 - $885,172	-38,286 Reduced 15.18%	213,897 $4.62 Million
Q3 2019 Oct 24, 2019	BUY	$16.91 - $36.27 $3.54 Million - $7.59 Million	209,243 Added 487.29%	252,183 $4.59 Million
Q2 2019 Oct 03, 2019	BUY	$31.0 - $36.3 $1.33 Million - $1.56 Million	42,940 New	42,940 $1.53 Million
Q2 2019 Jul 16, 2019	SELL	$31.0 - $36.3 $2.65 Million - $3.1 Million	-85,340 Closed	0 $0
Q1 2019 Oct 03, 2019	BUY	$31.58 - $46.35 $2.7 Million - $3.96 Million	85,340 New	85,340 $2.87 Million
Q1 2019 Apr 08, 2019	SELL	$31.58 - $46.35 $1.4 Million - $2.06 Million	-44,408 Closed	0 $0
Q4 2018 Oct 03, 2019	BUY	$30.43 - $56.65 $1.35 Million - $2.52 Million	44,408 New	44,408 $1.46 Million

142

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $231M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Railway Pension Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Railway Pension Investments LTD with notifications on news.